|
FY2026
12 months to Mar 31, 2026
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|
| Revenue | ||||
| Cost of Sales | ||||
| Gross Profit | ||||
| Sales, general and administrative costs | ||||
| Salaries and administration | ||||
| Depreciation | ||||
| Product development costs | ||||
| Office expense | ||||
| Insurance | ||||
| Professional fees | ||||
| Sales and marketing | ||||
| Share-based payments | ||||
| Transportation costs | ||||
| Travel, accomodation, meals and entertainment | ||||
| Allowance for credit losses | ||||
| Total sales, general and administrative costs | ||||
| Loss from operations before interest, accretion and foreign exchange | ||||
| Interest and accretion | ||||
| Other Income | ||||
| (Loss) on disposal of equipment | ||||
| Foreign exchange gain | ||||
| Loss from operations for the year | ||||
| Other items | ||||
| Debt extinguishment costs | ||||
| Series A convertible Preferred shares change in fair value | ||||
| Write down of assets | ||||
| Loss for the year before income tax | ||||
| Income tax | ||||
| Income tax recovery | ||||
| Loss for the year | ||||
| Other comprehensive income | ||||
| Cumulative translation reserve | ||||
| Total comprehensive loss for the year | ||||
| Loss per common share, basic | ||||
| Loss per common share, diluted | ||||
| Weighted average number of common shares outstanding, basic | ||||
| Weighted average number of common shares outstanding, diluted |
Loading...
